Wolters Kluwer agrees to buy clinical AI company AgileMD for up to $100 million

Wolters Kluwer Health has agreed to buy AgileMD, adding a route for its UpToDate medical guidance to reach clinicians inside their everyday care systems. Announced November 13, 2026, the deal is worth up to $100 million, with most of the price contingent on performance rather than guaranteed upfront.

Two different jobs at the point of care

AgileMD supplies clinical decision-support software: tools that help healthcare professionals apply guidance and use predictive analytics during care. Its two named products address different tasks. Pathways brings local clinical guidelines into electronic health records, while eCART provides real-time, AI-powered clinical surveillance.

Pathways turns a healthcare organization’s local guidelines into interactive clinical pathways within the record system. Wolters Kluwer describes its role as supporting consistency in care and measuring outcomes. That makes local guidance part of the workflow clinicians already use, rather than simply a body of reference information.

The surveillance product has a different purpose. Wolters Kluwer describes eCART as FDA-cleared and designed to help reduce mortality rates. That is the buyer’s description of its intended benefit, not a new finding about patient outcomes from this acquisition announcement.

$40 millionUpfront payment

The agreement specifies $40 million upfront; the balance of the potential $100 million price depends on performance targets.

UpToDate supplies the medical knowledge

Wolters Kluwer’s stated goal is to combine AgileMD with UpToDate Expert AI and its partnerships. Yaw Fellin, senior vice president of Wolters Kluwer Clinical Solutions, said AgileMD would help extend UpToDate into embedded workflows, local guidelines and new digital health applications.

AgileMD co-founder and CEO Borna Safabakhsh described the connection from the other direction: UpToDate’s capabilities would help AgileMD develop and maintain more advanced clinical pathways for complex decisions. The proposed combination therefore joins medical knowledge with software for putting local guidance into use; the executives describe that integration as work ahead.

The buyer brings an existing hospital audience. Wolters Kluwer says UpToDate Expert AI has been adopted by more than 2,700 U.S. hospitals and health systems since its September 2025 introduction. It puts adoption at more than 95% of its U.S.-based UpToDate Enterprise Edition customers.

A small team, with payments tied to performance

AgileMD is based in San Francisco and was founded in 2011. It is led by co-founders Safabakhsh and chief medical officer Dr. Dana Edelson. Wolters Kluwer says all 23 employees will join its health division, bringing the team behind the clinical tools into the buyer’s business.

The acquisition announcement projects AgileMD will reach $7 million in annual recurring revenue by year-end 2026. That figure is a forecast for recurring business, not a reported full-year revenue result. The deferred purchase payments depend on performance targets, but Wolters Kluwer did not disclose those targets in its financial terms.

Wolters Kluwer expects an immaterial effect on adjusted earnings. It also expects the acquisition’s return on invested capital to meet or exceed its 8% after-tax cost of capital within three to five years—a financial expectation distinct from the clinical benefits it hopes the combined products will deliver.

The acquisition still requires customary closing conditions and governmental approvals. Wolters Kluwer expects it to close in the first quarter of 2027 or sooner; the signed agreement does not yet make AgileMD part of the company.